| Date | Title | Description |
| 27.03.2026 | Every Cure’s drug repurposing strategy isn’t what you think, and it could change rare disease treatment | Every Cure is using AI to seek new uses for the roughly 4,000 existing drugs, and cutting traditional preliminary research timelines from as much as 100 days to as little as 17 hours.
Treatment for a specific disease is not the focus; inste... |
| 01.02.2026 | Focus on biopharma comes at the right time: Industry | - |
| 12.12.2025 | New UK-Singapore partnership aims to bring new medical innovations to patients faster | New: You can now listen to articles.
This audio is generated by an AI tool.
SINGAPORE: A first-of-its-kind partnership between Singapore and the UK could allow patients in both countries to benefit sooner from major medical advances, the He... |
| 08.11.2025 | 2025 Aurora Prize for Awakening Humanity Awarded to Dr. Jamal Eltaeb | Head of Al Nao Hospital in Sudan recognized for sustaining critical medical care amid civil war
and saving hundreds of lives
NEW YORK, Nov. 8, 2025 /PRNewswire/ -- The Aurora Humanitarian Initiative announced Thursday evening that Dr. Jamal... |
| 14.10.2025 | Американский AI-стартап Lila Sciences привлек $115 млн при оценке в $1,3 млрд | С учётом нового раунда общие инвестиции в Lila Sciences в рамках Series A достигли $350 млн, а суммарный капитал, привлечённый компанией с момента основания, составил $550 млн, что отражает высокий интерес инвесторов к научным открытиям с и... |
| 30.09.2025 | 2026 CNBC Changemakers nominations: Why women business leaders on our annual list are more important than ever | CNBC is now accepting nominations for the 2026 Changemakers list. Learn more and submit a nomination by Nov 21.
CNBC is now accepting nominations for the 2026 Changemakers list featuring women transforming business and philanthropy.
Women h... |
| 23.09.2025 | Flagship Pioneering Appoints Yvonne Hao as Chief Operating Officer and General Partner | , a scientific innovation engine for transformative platforms and products, announced the appointment of
as Chief Operating Officer and General Partner. Hao is a seasoned leader, investor, and operator with more than 25 years of experience ... |
| 18.09.2025 | Flagship Pioneering Unveils Extuitive to Revolutionize Consumer Product Innovation and Creative Marketing Using Next-Gen AI | , a scientific innovation engine for platforms and products, today unveiled Extuitive, an AI-first company built to help small businesses grow by redefining how consumer products and targeted creative content are designed, validated, and la... |
| 03.07.2025 | Terrana Biosciences Raises $50M From Flagship Pioneering | Terrana Biosciences, a Cambridge, MA-based company providing RNA-based agricultural solutions, received $50M from Flagship Pioneering.
The company intends to use the funds to scale operations and develop its first products in crop protectio... |
| 13.06.2025 | Signify Bio: $15 Million Raised For Creating Personalized Medicines | Signify Bio, which is a pioneering biotechnology company harnessing the human body for the production of in situ protein therapeutics, announced an oversubscribed $15 million initial financing.
The funding round was led by Actium Group with... |
| 07.05.2025 | Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development | Collaboration Aims to Expand Globally Connected Scientific Dialogue and Accelerate Innovation in Human Health and Sustainability
SINGAPORE, May 7, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, the Yong Loo Li... |
| 24.04.2025 | Etiome emerges with $50M from Flagship Pioneering and goal of preempting disease | A new biotech is hitting the Boston scene with $50 million from Flagship Pioneering and a goal of preventing patients from ever getting seriously sick in the first place.
Etiome has spent the last four years quietly building a platform to m... |
| 06.04.2025 | Pillar VC's New Fund: A Catalyst for Scientific Innovation | Pillar VC has struck gold with its latest venture, closing a $175 million Fund IV. This move elevates the firm’s total assets under management to over $500 million. It’s a bold step into the future, one that promises to bridge the gap betwe... |
| 04.04.2025 | Pillar VC: $175 Million Fund IV Closed | Pillar VC recently announced its $175 million Fund IV, bringing the firm’s total assets under management to more than $500 million. And Pillar VC is also introducing three new Venture Partners, and four new Founding Pillars, a group of CEOs... |
| 28.03.2025 | Ampersand Biomedicines: Series B Raised For Developing Smarter Medicines | Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, announced it has secured $65 million in Series B funding from investors including Ampersand... |
| 19.03.2025 | Ampersand Biomedicines Raises $65M in Series B Financing | Ampersand Biosciences, a Boston, MA-based multi-product platform company developing smart medicines, raised $65M in Series B Funding.
Backers included Ampersand’s founder, Flagship Pioneering, Eli Lilly & Company, and several additional... |
| 12.03.2025 | The Dawn of Autonomous Science: Lila Sciences and the Future of Discovery | In the world of scientific research, a new player has emerged, promising to change the game. Lila Sciences, a startup born from the innovative incubator Flagship Pioneering, has raised a staggering $200 million in seed funding. This infusio... |
| 12.03.2025 | Lila Sciences: $200 Million (Seed) Raised For Scientific Superintelligence Platform | Bioplatform innovation company Flagship Pioneering has unveiled Lila Sciences, a company building the world’s first scientific superintelligence platform and fully autonomous labs for life, chemical, and materials sciences. Lila raised $200... |
| 10.03.2025 | Lila Sciences raises $200M to accelerate autonomous scientific research
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to provide f... | Artificial intelligence-powered scientific discovery startup Lila Sciences is the latest company to emerge from Flagship Pioneering Inc.’s biotechnology incubator, and it’s backed by a staggering $200 million in seed funding.
The startup, w... |
| 18.02.2025 | Swim Across America Welcomes Two New Board Members: Harry Wilcox and Tim Buttigieg | Wilcox and Buttigieg Bring Biotech, Science, Financial, Hospitality and Real Estate Expertise to Help Grow Swim Across America's Impact and Mission
CHARLOTTE, N.C., Feb. 18, 2025 /PRNewswire-PRWeb/ -- Swim Across America, a national nonprof... |
| 08.01.2025 | Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseases | Scope of collaboration originally signed in 2023 will significantly expand to enable the discovery and development of up to 20 novel drug programmes in obesity, type 2 diabetes, and cardiovascular disease
Expanded collaboration includes nea... |
| 07.01.2025 | Inari Agriculture Raises $144M in Funding | Inari Agriculture, a Cambridge, MA-based seed design company, raised $144M in funding.
Backers included Abu Dhabi Investment Authority (ADIA), and a large financial investor collaborating on forthcoming agriculture projects. Existing invest... |
| 07.01.2025 | Seed gene-editing startup Inari eyes commercialization with $144m round: ‘It puts us in a robust financial position’ | Seed gene-editing startup Inari has completed a $144 million Series G round, bringing its cumulative funding to $720 million.
New investors include a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) and a large financial... |
| 07.01.2025 | Inari: Seed Technology Company Secures $144 Million | Inari announced the completion of a $144 million fundraise driven by the performance of its first-generation products and progress toward commercialization. And with cumulative equity raised of over $720 million, the new capital supports th... |
| 18.12.2024 | Samsung's Bold Leap into Biomedicine: A New Era of AI-Driven Therapeutics | In the fast-paced world of biomedicine, Samsung is making waves. The tech giant has set its sights on revolutionizing the biopharmaceutical landscape through strategic investments and a commitment to sustainability. With its recent investme... |
| 18.12.2024 | Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery | - Samsung Life Science Fund invests in Generate:Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics discovery and development
- Investment highlights Samsung's dedication to advancing innovation and creati... |
| 29.10.2024 | HongShan and Li-Ning form rare joint venture to fuel global expansion | On October 22, Chinese sportswear company Li-Ning entered new territory, announcing a joint venture with venture capital firm HongShan (formerly Sequoia China) to expand beyond mainland China.
The structure of the joint venture is straightf... |
| 03.10.2024 | A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore | Organizations Plan to Jointly Advance Breakthrough Solutions in Human Health and Sustainability, Drive Research Collaboration, Entrepreneurship and Accelerate Talent Development
SINGAPORE, Oct. 3, 2024 /PRNewswire/ -- The Agency for Science... |
| 28.08.2024 | Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer | Collaboration leverages Quotient's platform to identify somatic mutations in genes that modify the progression of cardiovascular and renal diseases
Quotient and Pioneering Medicines, Flagship's in-house drug development unit, will jointly c... |
| 06.08.2024 | Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner | Former White House Top Health Security Official to Lead Flagship's Preemptive Health and Medicine Initiative
CAMBRIDGE, Mass., Aug. 6, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced that global... |
| 30.07.2024 | The New Frontier in Biotech: Partnerships and Innovations Shaping the Future of Medicine | In the ever-evolving landscape of biotechnology, partnerships are the lifeblood of innovation. Two recent collaborations highlight this trend: GSK's partnership with Flagship Pioneering and Autobahn Therapeutics' successful funding round. B... |
| 29.07.2024 | GSK and Flagship Pioneering partner to discover novel medicines and vaccines | Collaboration brings together GSK disease area expertise and development capability with Flagship portfolio of 40+ bioplatform companies
Initial phase to identify and accelerate promising scientific concepts for further research starting in... |
| 29.07.2024 | GSK partners with Flagship Pioneering to develop medicines and vaccines | The two companies have agreed to jointly fund up to $150M upfront to identify promising concepts
Flagship Pioneering is a biotechnology company that creates and funds bioplatform companies; since its founded in 2000, it has developed more t... |
| 23.07.2024 | Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Class | The Abiologics platform leverages cutting-edge generative AI and high throughput chemical protein synthesis to create Synteins™, a new class of programmable medicines that aims to redefine what therapeutics can achieve for patients
The comp... |
| 11.07.2024 | The Week in AgriFoodTech: $3.6bn for Flagship Pioneering, $379m for Kembara, $10m for Cartken’s delivery bots | While there was a dearth of funding rounds for agrifoodtech startups this week, some serious money was pumped into adjacent spaces.
Kembara’s deeptech and climate fund secured a €350 million ($379 million) capital injection from the Europea... |
| 10.07.2024 | Flagship Pioneering Expands Leadership Team with Key Appointments and Promotions | CAMBRIDGE, Mass., July 10, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced additions to its leadership team through key executive appointments and promotions. Today's personnel announcement acco... |
| 10.07.2024 | Flagship Pioneering Raises $3.6 Billion to Fuel Breakthrough Innovations that Transform Human Health and Sustainability | Record Year with Key Partnerships, Global Expansion and Expanded Top Talent
CAMBRIDGE, Mass., July 10, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced it has expanded its capital base by $3.6 bi... |
| 12.06.2024 | Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer | First exploration agreement initiated under strategic partnership between Flagship and Pfizer to accelerate the development of innovative medicines
Collaboration leverages ProFound's proprietary ProFoundry™ Platform to identify potential no... |
| 22.05.2024 | Meatable appoints beef industry veteran as CEO | Listen to the article 3 min
This audio is auto-generated. Please let us know if you have feedback. Dive Brief:
Meatable, a foodtech company looking to deliver cultivated meat at scale, appointed Jeff “Trip” Tripician as CEO, effective June ... |
| 07.05.2024 | Prologue Medicines Raises $50M in Funding | Prologue Medicines, a Cambridge, MA-based company advancing therapeutics that leverage the viral proteome, received a $50m investment from Flagship Pioneering.
The company intends to use the funds to advance its Decoding Evolutionary Logic ... |
| 08.04.2024 | Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences | O'Shea is a Seasoned Global Executive with more than 20 Years' Experience across the Agriculture, Food and Pharmaceutical Industries
CAMBRIDGE, Mass., April 8, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, an... |
| 21.03.2024 | Biological progress or bathtub brews? The state of US crop biologicals in 2024 | Bathtub brew. Snake oil. Bugs in a jug. For years, companies developing biologicals — a form of crop protection derived from naturally occurring substances like microbes, peptides, and plants — have labored under the shadow of these labels,... |
| 20.03.2024 | Casper’s co-founder is helping launch an incubator for climate tech startups | Hundreds of climate-related startups have been founded in recent years, but for Casper co-founder Philip Krim, that’s not nearly enough.
“We need a lot more zero-to-one founders in this ecosystem,” he told TechCrunch. Relative to other indu... |
| 19.03.2024 | Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024 | Ranked #3 Most Innovative Company in North America Recognized for the Third Consecutive Year
CAMBRIDGE, Mass., March 19, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, has been named to Fast Company's prestigi... |
| 09.01.2024 | AI copilots and robo-labs turbocharge research | Laboratory "copilots" and automated labs are AI's latest contribution to speeding up the development of new drugs, chemicals and materials.
Why it matters: Scientific discovery itself must speed up if the world is to address its c... |
| 08.01.2024 | JPM24: Flagship chief says firm will have to ‘do some work’ before linking with China-based partners | Flagship went global last year, opening new offices in London and Singapore as part of a concerted expansion of the venture creation firm’s startup ecosystem. But it may be a bit before the Asia-Pacific outpost spurs new partnerships in Chi... |
| 08.11.2023 | Flagship Pioneering Expands into Asia-Pacific Region, with Regional Hub in Singapore | André Andonian Joins Flagship to Lead APAC Region
SINGAPORE, Nov. 8, 2023 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced its expansion into the Asia-Pacific region, with the opening of a regional hu... |
| 02.11.2023 | Flagship Pioneering Launches Pioneering Intelligence | Flagship Pioneering launched Pioneering Intelligence, an initiative of Flagship Pioneering harnessing artificial intelligence (AI) to accelerate innovation in the life sciences and beyond. Flagship marked the official launch of Pioneering I... |
| 21.06.2023 | One of biotech’s biggest financiers launches small-molecule startup, in spite of IRA’s looming shadow | It’s been nearly a year since Congress passed the Inflation Reduction Act, raising a chorus of drug executive and investor complaints that it would decimate the development of small-molecule medicines. After all, it opens the door for Medic... |
| 10.01.2023 | The billionaire CEO of a top biotech VC firm details how a new type of AI could transform how we test and discover treatments | Flagship Pioneering CEO Noubar Afeyan. Flagship Pioneering
Artificial intelligence has the power to revolutionize biotech, Noubar Afeyan says.
Afeyan is the CEO and founder of Flagship Pioneering, the venture firm behind Moderna.
Flagship h... |
| 04.10.2022 | Flagship-founded Cellarity tacks on $121M series C to fund cell behaviour pipeline | Flagship-founded Cellarity has hauled in $121 million in new series C funds as the biotech continues to push its cell behavior therapies toward the clinic.
The latest financing round, announced Tuesday, brings the company’s total raised to ... |
| 27.05.2022 | Biotech Start-Up Finds Overlooked Proteins That Could Cure Diseases | If you were under the impression that our genome had about 20,000 genes, each a recipe for a different protein, you’re not alone. The Human Genome Project celebrated the first mapping of those 20,000 genes two decades ago.
But a new start-u... |
| 18.05.2022 | Biotech stocks are getting crushed — but industry insiders say there’s reason for optimism | The SPDR S&P Biotech ETF (XBI), a key biotech index fund. (Google screenshot)
Biotech is coming off an epic few years. The sector soared during the pandemic, with venture capital investment and IPO volumes hitting all-time highs.
But re... |
| 20.04.2022 | Agriland Inc. Farm Management & Realty Leverages CIBO Carbon Bridge Program to Support Transition to Regenerative Agriculture | "I am happy to partner with CIBO Carbon Bridge to begin generating carbon credits on my farm this year. CIBO understands the many challenges facing farmers and their adoption of regenerative practices,” said Patrick White, Agriland Inc... |
| 15.02.2022 | In a nail-biter, Rob Califf gets a second shot at FDA commissioner with Senate confirmation | Famed cardiologist, Duke University clinical trial researcher and former FDA commissioner Rob Califf won Senate confirmation for the second time on Tuesday, after more than a year without an appointed leader at the agency.
This time, after ... |
| 25.01.2022 | Flagship Pioneering Announces Appointment of Tom DiLenge as Senior Partner, Global Public Policy, Regulatory & Governmental Strategy | CAMBRIDGE, Mass., Jan. 25, 2022 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that Tom DiLenge has joined the company in a newly created role as Senior Partner, Global Public Policy, Regulatory &am... |
| 24.01.2022 | CIBO Adds Grower and Consumer Packaged Goods Industry Expertise with New Senior Hires | “Michael and Travis bring critical knowledge and expertise to our leadership team that will help to maximize the impact and value we bring to CPG companies and growers.” said Daniel Ryan, chief executive officer at CIBO Technologies.
CAMBRI... |
| 14.01.2022 | 'Shots on goal' to 'deterministic' drug development: Flagship CEO, Moderna Chair Afeyan pens first annual letter | The founder of Moderna’s incubator, Flagship Pioneering, penned his first annual letter charting the four driving forces behind the biotech industry’s future with an emphasis on digital biology and platform technologies.
Noubar Afeyan, Ph.D... |
| 14.01.2022 | 'Shots on goal' to 'deterministic' drug development: Flagship CEO, Moderna Chair Noubar Afeyan pens first annual letter | The founder of Moderna’s incubator, Flagship Pioneering, penned his first annual letter charting the four driving forces behind the biotech industry’s future with an emphasis on digital biology and platform technologies.
For a letter addres... |
| 07.12.2021 | Flagship Pioneering Launches Harbinger Health to Detect Early Cancer with a Simple, Bio-AI Based Blood Test | CAMBRIDGE, Mass., Dec. 7, 2021 /PRNewswire/ -- Flagship Pioneering today announced the launch of Harbinger Health, a bioplatform company pioneering the detection of early cancer with a simple blood test that combines Artificial Intelligence... |
| 07.12.2021 | Former FDA head Hahn takes helm of cancer blood test maker Harbinger Health | While many new medtech startups spend their first few years struggling to rack up enough capital and cachet to bring their ideas to fruition, Harbinger Health, which emerged from stealth just this week, already has both of those assets in s... |
| 07.12.2021 | Former FDA head Hahn takes helm of cancer blood test maker Harbinger Health | While many new medtech startups spend their first few years struggling to rack up enough capital and cachet to bring their ideas to fruition, Harbinger Health, which emerged from stealth just this week, already has both of those assets in s... |
| 15.11.2021 | Flagship Pioneering Announces Appointment of Justine Levin-Allerhand as Senior Partner, Corporate Development | CAMBRIDGE, Mass., Nov. 15, 2021 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that Justine Levin-Allerhand, Ph.D., has joined the company in a newly created role as Senior Partner, Corporate Develo... |
| 09.11.2021 | CIBO Announces November 2021 County-Level Yield Forecasts for U.S. Crops | CIBO Announces November 2021 County-Level Yield Forecasts for U.S. Crops “We’re pleasantly surprised and hope a better than expected harvest could help provide stability when it comes to food prices," said Dustin Madison, agronomy cons... |
| 09.11.2021 | Flagship Pioneering’s new venture is betting on tRNA to treat ‘thousands of diseases’ | On Tuesday, Flagship Pioneering, the major investor behind Moderna, announced yet another addition to their portfolio of RNA-curious companies. Following a year of hype around mRNA, a new company, called Alltrna, will now focus on developin... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | With NIBR chief Jay Bradner serving as the in-house expert on protein degradation, Novartis has its standards for the technology. A small transatlantic startup is clearly ready to meet them.
Dunad, a new player that emerged in the field in ... |
| 03.11.2021 | Antios Therapeutics' hep B candidate gets another round of applause from investors, closing out a $171M megaround | Antios Therapeutics, the Atlanta biotech that was the brainchild of former hep C pioneer Pharmasset executive and former Antios CEO Abel De La Rosa, announced this morning that the biotech raised $75 million in a Series ... |
| 03.11.2021 | Sage changes primary endpoint in key study months after analysts fret about depression drug's durability | Only a few days after President Joe Biden seemed to signal that drug pricing reforms were left for dead, Democrats are already circulating plans for a scaled-back version of what they wanted initially, although with more limited Medicare ne... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | When Chad Cowan was recruited to Harvard University 20 years ago to work on human embryonic stem cells, he was inspired by the idea that these specialized cells could be used to make insulin-producing beta cells and potentially cure Type 1 ... |
| 03.11.2021 | PhaseBio claims positive PhII in platelet inhibition reversal; Trial software firm rebrands after hack, merger | Aiming to bring new cardiopulmonary drugs to market, PhaseBio took one step closer toward that goal Wednesday morning.
The biotech reported positive topline results for a Phase IIb study evaluating the drug bentracimab in ... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | Johnson & Johnson is looking for big ideas from small entrepreneurs. Spurred by the pandemic health inequities and ongoing racial injustice in local communities, J&J is running a new innovation challenge in six hard-hit cities. And ... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | Democrats patted each other on the back for officially coalescing around a prescription drug plan that will let Medicare negotiate a limited set of drug prices, but analysts are already poking holes in the Dems’ plans and there’s a lot stil... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | It’s probably not an exaggeration to say that all eyes in the marketing world are on Kate Cronin. Maybe not specifically on Cronin by name, but most definitely on the Moderna brand she is shepherding as the biotech’s first chief brand offic... |
| 03.11.2021 | Covid-19 roundup: Eli Lilly withdraws mAbs from EMA review | The World Health Organization has granted Indian-produced Covid-19 vaccine emergency use listing, adding to its portfolio of acceptable vaccines.
A advisory group determined that Covaxin, produced by Indian drugm... |
| 03.11.2021 | Sage changes primary endpoint in key study months after analysts fret about depression drug's durability | In its quest to deliver a new drug to treat major depressive disorder, Sage Therapeutics recently updated its Phase III study with a change analysts believe gives the biotech a better chance at FDA approval.
Sage altered... |
| 03.11.2021 | Sage changes primary endpoint in key study months after analysts fret about depression drug's durability | ALS has proven to be one of the most challenging diseases for drug development, with only two approved medicines since the mid-1990s showing mild effects at slowing disease progression. Tuesday morning, another biotech attempting to create ... |
| 03.11.2021 | Pioneering Medicines, An Initiative Of Flagship Pioneering, Establishes First-Of-Its-Kind Partnership With The Cystic Fibrosis Foundation To Develop Breakthrough Treatments For CF | CAMBRIDGE, Mass., Nov. 3, 2021 /PRNewswire/ -- Flagship Pioneering today announced a first-of-its-kind strategic partnership with the Cystic Fibrosis Foundation and Flagship's Pioneering Medicines to develop therapeutics that address the un... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | Moderna has always been thinking about how mRNA could transform the gene editing space, according to Eric Huang. In fact, they looked at it about a decade ago — but at the time, they were still a small, preclinical biotech, and technology l... |
| 03.11.2021 | Sage changes primary endpoint in key study months after analysts fret about depression drug's durability | If David Reese gets his way, Lumakras will be the first of many Amgen drugs that shatter the fences currently cordoning off vast swaths of protein targets as “undruggable.”
Lumakras, the groundbreaking KRAS G12C inhibitor 40 years in the ma... |
| 03.11.2021 | Bayer backs a George Church spinout trying to turn lab-invented amino acids into a new class of protein therapies | Six years ago, Daniel Mandell appeared on NPR to talk about an invention out of Jurassic Park.
As Crichton and Goldblum fans recall, International Genetic Technologies, Inc.’s contingency plan to make sure dinosaurs didn’... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | Welcome to Endpoints MarketingRx, the new weekly about pharma marketing, advertising and drug commercialization.
The newsletter launch begs an old question though: what is pharma marketing and why does it matter?
To some people, pharma mark... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | Even while serving as the global R&D head for Teva several years ago, Michael Hayden had high hopes for a drug known as pridopidine. But he wasn’t always on the right track.
Researchers originally believed the drug, now the lead asset o... |
| 02.11.2021 | Pfizer reveals delays across the board for its clinical gene therapy programs | At JP Morgan 2020, a year after taking the reins at Pfizer, Albert Bourla claimed the company was poised to become a leader in gene therapy. He’s since thrown hundreds of millions of dollars at those plans, including a $630 m... |
| 02.11.2021 | Fresh off Kite and BeiGene deals, Shoreline ups the ante with a hefty crossover. But the biotech insists it's in no rush | Though it may seem like Shoreline Biosciences is rapidly gaining momentum with a flurry of deals — and, now, a new funding round — Kleanthis Xanthopoulos doesn’t feel he’s in a rush.
The biotech’s chief executive put the bow o... |
| 02.11.2021 | Leading proteomics player gets a trio of new partners; GV tries to prevent cervical cancer | A little over 6 months ago, John Baker got on a call from a CEO with a strange request.
Baker is head of innovation at Abcam, a British company that provides life science research tools to labs and companies around the world.... |
| 02.11.2021 | Covid-19 roundup: Pfizer raises 2021 vaccine sales forecast to $36B; Lilly lands $1.3B treatment deal with US government | Pfizer’s Covid-19 vaccine in 2021 is quickly becoming the best-selling medical product of all time in terms of annual sales.
The company on Tuesday reported its quarterly earnings and re-upped its yearly guidance on its ... |
| 02.11.2021 | FDA pushes back decision on J&J, Legend's BCMA CAR-T | Bristol Myers Squibb and bluebird can hold on to their status as the makers of the only approved BCMA CAR-T for a bit longer.
The FDA — which was scheduled to make a decision on Legend and J&J’s cilta-cel on Nov. 29 — has d... |
| 26.10.2021 | BREAKING: Indigo Ag acquires Soil Metrics to boost carbon MRV capabilities | Indigo Ag has acquired Soil Metrics, a firm which carries out assessments of soil carbon sequestration, for an undisclosed sum.
The pair had already partnered on the acquirer’s Carbon by Indigo program, which works with farmers to generate ... |
| 21.10.2021 | BREAKING: CIBO Technologies raises $30m Series C funding for carbon trading tools | US carbon trading platform CIBO Technologies has raised $30 million in Series C funding, it said in a statement.
The Cambridge, Massachusetts-based company indicated that the funds will be used to boost the commercialization of its monitori... |
| 13.10.2021 | Analysis: how work is built in a startup studio | Analysis: how work is built in a startup studio |
| 13.10.2021 | Разбор: как строится работа в стартап-студии | Разбор: как строится работа в стартап-студии |
| 12.10.2021 | CIBO Announces October 2021 County-Level Yield Forecasts for U.S. Crops | “To combat these challenges, businesses and growers are looking to regenerative agriculture and other solutions to grow climate-resilient crops to help reduce costs and risk," said Brian Sutton, President and Founder of AirScout with f... |
| 29.09.2021 | Myths about startup studios | Myths about startup studios |
| 29.09.2021 | Мифы о работе стартап-студий | Мифы о работе стартап-студий |
| 15.09.2021 | Flagship Pioneering Announces Appointment of Kathy Biberstein as General Counsel | |
| 10.09.2021 | CIBO Announces September 2021 County-Level Yield Forecasts for U.S. Crops | “CIBO’s yield forecasts help farmers and other agricultural decision-makers have the up-to-the-minute information they need to understand how national yield and weather impacts come to life on their farms and in their local counties," ... |
| 19.08.2021 | CIBO Named “AI-based AgTech Company of the Year” In 2021 AgTech Breakthrough Awards Program | “This recognition from AgTech Breakthrough helps validate our path forward. CIBO will continue working towards real, measurable impact in sustainability,” said Daniel Ryan, CEO, CIBO.
CAMBRIDGE, Mass. and MINNEAPOLIS, Minn., (PRWEB) August ... |
| 16.08.2021 | CIBO Announces August 2021 County-Level Yield Forecasts for U.S. Crops | “Implementing regenerative agricultural practices helps us create climate resiliency in our fields," said Matt Leischner, Co-Owner of South Branch Farms. "Our focus on cover cropping, no-tillage, and smarter input selection helps ... |
| 28.07.2021 | Ring Therapeutics : Raises $117 Million in Series B Funding to Expand Novel Vector Platform to Unlock the Full Potential of Gene Therapy | CAMBRIDGE, Mass., July 28, 2021 /PRNewswire/ -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its commensal virome platform, announced today that it raised $117 million in Serie... |
| 14.06.2021 | The broader implications of Lordstown’s failures | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
The boom in special purpose acquisition companies has helped some new-generation vehicle makers t... |
